Ionis Pharmaceuticals
IONS
IONS
347 hedge funds and large institutions have $4.58B invested in Ionis Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 52 funds opening new positions, 89 increasing their positions, 128 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.37% less ownership
Funds ownership: 88.19% → 87.82% (-0.37%)
1% less capital invested
Capital invested by funds: $4.62B → $4.58B (-$41.9M)
30% less repeat investments, than reductions
Existing positions increased: 89 | Existing positions reduced: 128
Holders
347
Holding in Top 10
4
Calls
$22.6M
Puts
$8.88M
Top Buyers
| 1 | +$48.1M | |
| 2 | +$26.6M | |
| 3 | +$18.1M | |
| 4 |
O
OrbiMed
New York
|
+$17.1M |
| 5 |
BlackRock
New York
|
+$14.6M |
Top Sellers
| 1 | -$55.4M | |
| 2 | -$37.8M | |
| 3 | -$28.8M | |
| 4 |
ClearBridge Investments
New York
|
-$17.7M |
| 5 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$11.3M |